The prevalence of HBOC varies across populations. Studies estimate that BRCA1 and BRCA2 mutations occur in approximately 1 in 400 individuals in the general population. However, certain ethnic groups, such as Ashkenazi Jews, have a higher prevalence, with mutation rates as high as 1 in 40 individuals. This highlights the importance of genetic screening in high-risk populations.
